In conclusion, we generated a risk model comprising the ROS-related genes PYCR1 and MELK, which may contribute to regulating the development of ccRCC progression and serve as independent prognostic factors for patients with ccRCC. Here, MELK is linked to nonpapillary renal cell carcinoma.